What Youth and Families Think About Type 1 Diabetes Screening: A New Study

Islet autoantibodies are markers in the blood that signal the body's immune system is targeting the cells that make insulin. When someone has one or more of these autoantibodies, it means their risk of developing Type 1 diabetes is higher than average. Screening programs around the world are beginning to test for these autoantibodies to identify people at risk before symptoms appear.

But little was known about what young people and their families actually think about these screening and monitoring programs. Do they find them helpful? Are they worried? Do they understand what the tests mean? A team of Australian researchers decided to find out by interviewing 35 young people and 49 caregivers.

The youth in the study—aged 9 to 18, and monitored for an average of 9 years—had been getting tested regularly for autoantibodies. When researchers asked them about screening, the young people mostly talked about the testing itself: what the needle felt like, how appointments fit into their schedule, whether the lab was easy to reach.

The study found that youth had limited understanding of why monitoring mattered for their health. Rather than thinking deeply about their diabetes risk, they were mainly focused on the practical experience of showing up for tests. While this might seem worrying at first, researchers noted it was actually reassuring in one way: young people weren't overly anxious about the testing process itself.

Caregivers told a different story. They reported strong emotional responses to screening and monitoring—worry, stress, and uncertainty about what the results meant for their child's future. The study found that family history shaped these feelings significantly. Twenty-one of the 49 caregivers (about 43%) were living with Type 1 diabetes themselves, and many others had a close relative with the condition. Their own experiences with diabetes influenced how they processed their child's screening results.

Older adolescents in the study also reported stronger emotional responses than younger youth, suggesting that as young people mature, they may become more aware of and concerned about their diabetes risk.

Beyond emotions and understanding, caregivers emphasized the importance of how screening programs actually work in practice. They wanted flexibility—programs that could adapt to their family's schedule and circumstances. They also highlighted specific logistical needs: reliable access to testing, clear communication about results, and support that fits into their lives.

The researchers concluded that while youth's focus on testing experiences rather than health risk is practical and manageable, there's an important gap to fill. Young people need education about the real-world benefits of monitoring. At the same time, families need access to psychosocial support—counseling, peer groups, or other resources—to help manage the emotional weight of knowing their child has autoantibodies and may develop Type 1 diabetes.

Source: Frontiers in endocrinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.